USD 11.85
(4.77%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 2.26 Billion | -15.52 Million | -211.41 Million | 574.74 Million | -923.96 Million |
Net Income | 2.22 Billion | 411.9 Million | -3.65 Billion | -3.47 Billion | -1.52 Billion |
Depreciation & Amortization | 74.74 Million | 88.34 Million | 67.42 Million | 63.66 Million | 70.7 Million |
Deferred income taxes | 222.06 Million | - | 392.42 Million | - | - |
Stock-based compensation | 441.82 Million | 919.25 Million | 3.62 Billion | 3.25 Billion | 455.63 Million |
Change in working capital | -708.86 Million | -1.7 Billion | -619.45 Million | 366.03 Million | -829.12 Million |
Other non-cash items | 12.79 Million | 265.14 Million | -25.87 Million | 361.17 Million | 902.47 Million |
Investing Cash Flow | 553.73 Million | 2.13 Billion | -14.39 Billion | -2.69 Billion | -3.39 Billion |
Investments in PPE | -100.34 Million | -85.68 Million | -43.22 Million | -53.06 Million | -10.41 Million |
Acquisitions | - | -75.08 Million | -230.48 Million | -17.72 Million | 2.06 Million |
Investment purchases | -20.94 Billion | -84.61 Billion | -24.22 Billion | -9.51 Billion | -6.55 Billion |
Sales/Maturities of investments | 21.59 Billion | 86.9 Billion | 10.09 Billion | 6.7 Billion | 3.17 Billion |
Other Investing Activities | 1.4 Million | 735 Thousand | 7.15 Million | 187.71 Million | -3.95 Million |
Financing Cash Flow | -1.16 Billion | -1.33 Billion | 8.9 Billion | 8.32 Billion | 1.69 Billion |
Debt repayment | - | -9 Million | - | -1.81 Billion | -1.23 Billion |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | -1.37 Billion | -1.39 Billion | -2.58 Billion | -557.83 Million | -384.88 Million |
Common Stock Issuance | - | - | 11.05 Billion | - | - |
Other Financing Activities | 207.82 Million | 71.2 Million | 427.9 Million | 10.69 Billion | 3.3 Billion |
Accounts receivables | -10.04 Million | 14.06 Million | 18.79 Million | -16.39 Million | -6.44 Million |
Accounts payables | -2.73 Million | -1.42 Million | 5.31 Million | 5.85 Million | -18.46 Million |
Inventory | -575.48 Million | - | -630.81 Million | 389.08 Million | -779.88 Million |
Other working capital | -120.61 Million | -1.71 Billion | -12.75 Million | -12.5 Million | -24.33 Million |
Cash at beginning of period | 5.22 Billion | 4.36 Billion | 10.16 Billion | 4.07 Billion | 6.68 Billion |
Cash at end of period | 6.89 Billion | 5.22 Billion | 4.36 Billion | 10.16 Billion | 4.07 Billion |
Capital Expenditure | -100.34 Million | -85.68 Million | -43.22 Million | -53.06 Million | -10.41 Million |
Effect of forex changes on cash | 18.95 Million | 71.93 Million | -87.67 Million | -127.77 Million | 19.88 Million |
Net cash flow / Change in cash | 1.67 Billion | 857.45 Million | -5.79 Billion | 6.08 Billion | -2.6 Billion |
Free Cash Flow | 2.16 Billion | -101.2 Million | -254.63 Million | 521.67 Million | -934.38 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 113.26 Million | 80.48 Million | 82.29 Million | 2.22 Billion | 84.14 Million | 83.45 Million |
Depreciation & Amortization | - | - | - | 74.74 Million | 1.79 Million | 1.85 Million |
Deferred income taxes | - | - | - | 222.06 Million | - | - |
Stock-based compensation | 16 Million | 21.59 Million | 18.41 Million | 441.82 Million | 16.73 Million | 13.73 Million |
Change in working capital | - | - | - | -708.86 Million | - | - |
Other non-cash items | -129.26 Million | -102.08 Million | -100.7 Million | 12.79 Million | -100.88 Million | -97.18 Million |
Investing Cash Flow | - | - | - | 553.73 Million | - | - |
Investments in PPE | - | - | - | -100.34 Million | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | -20.94 Billion | - | - |
Sales/Maturities of investments | - | - | - | 21.59 Billion | - | - |
Other Investing Activities | - | - | - | 1.4 Million | - | - |
Financing Cash Flow | - | - | - | -1.16 Billion | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | -1.37 Billion | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | 207.82 Million | - | - |
Accounts receivables | - | - | - | -10.04 Million | - | - |
Accounts payables | - | - | - | -2.73 Million | - | - |
Inventory | - | - | - | -575.48 Million | - | - |
Other working capital | - | - | - | -120.61 Million | - | - |
Cash at beginning of period | - | - | - | 5.22 Billion | 985.03 Million | 1 Billion |
Cash at end of period | - | - | - | 6.89 Billion | 936.33 Million | 985.03 Million |
Capital Expenditure | - | - | - | -100.34 Million | - | - |
Effect of forex changes on cash | - | - | - | 18.95 Million | - | - |
Net cash flow / Change in cash | - | - | - | 1.67 Billion | -48.7 Million | -20.57 Million |
Free Cash Flow | - | - | - | 2.16 Billion | 3.59 Million | 3.7 Million |
IOVA
000820
TXAR
ZZHGF
OMMSF
SU